Business Wire·Nov 10, 2026, 4:05 PM ET

QT Imaging Reports 75% Third Quarter Revenue Growth and Major Medicare Reimbursement Milestone

QT Imaging reported Q3 2026 revenue of $7.3 million & year-to-date revenue of $21.3 million, representing a 75% year-over-year increase.
The company sold 43 Breast Acoustic CT scanners year-to-date, with 15 units sold in the third quarter alone.
CMS established a separate Medicare hospital outpatient payment for diagnostic QTscan examinations effective January 1, 2027, assigning CPT code 1079T.
Full-year 2026 revenue guidance was adjusted downward to approximately $34 million due to shipment delays caused by the war in the Middle East & closed shipping routes.
U.S. scanner shipments remain on plan despite international disruptions in Saudi Arabia & the UAE.
Manufacturing capacity doubled following a relocation to a new 22,000-square-foot facility in Petaluma, California, which successfully passed its first FDA inspection with zero observations.
The company secured its first major international order from American Hospital Dubai & received regulatory authorization in Israel & Bahrain.
Operating loss for Q3 2026 was $2.4 million, while net loss improved to $0.3 million due to a $2.4 million noncash gain from the change in fair value of the earnout liability.
Cash & equivalents totaled $8.4 million as of September 30, 2026, with accounts receivable of $7.3 million collected in full by the end of October.
QT Imaging management hosted a conference call on November 4, 2026, at 4:30 p.m. Eastern time to discuss financial results & business updates.